Two major studies published in 2026 have converged on a sobering conclusion about women and heart disease in America: the medical system is consistently failing women at two distinct points in their cardiovascular health journey. The first failure occurs during perimenopause, when estrogen and progesterone levels begin their permanent decline and cardiovascular risk rises sharply — a change that is often not addressed because many clinicians, and many women themselves, do not recognize the menopausal transition as a cardiovascular health event. The second failure occurs later, when women who develop advanced heart failure are significantly less likely to be referred for life-saving treatments than men with the same clinical burden.
Together, the data describe a pipeline of missed opportunities that begins in midlife and ends at the threshold of the most aggressive interventions medicine has to offer — with women systematically less likely to access either early prevention or late-stage rescue.
